ホーム>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> Diabetes>>Montbretin A

Montbretin A (Synonyms: MbA)

カタログ番号GC52032

抗糖尿病活性を持つアシル化フラボノールグリコシド

Products are for research use only. Not for human use. We do not sell to patients.

Montbretin A 化学構造

Cas No.: 115712-92-0

サイズ 価格 在庫数 個数
1 mg
$316.00
在庫あり
5 mg
$1,027.00
在庫あり
10 mg
$1,420.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Montbretin A is an acylated flavonol glycoside that has been found in C. crocosmiiflora and has antidiabetic activity.1,2,3 It inhibits human pancreatic α-amylase and B. fibrisolvens amylase B (Kis = 8.1 and 1,600 nM, respectively).2 Montbretin A reduces blood glucose levels in Zucker diabetic fatty rats when administered at a dose of 7.4 mg/kg per day.4

1.Asada, Y., Hirayama, Y., and Furuya, T.Acylated flavonols from Crocosmia crocosmiifloraPhytochemistry27(5)1497-1501(1988) 2.Williams, L.K., Zhang, X., Caner, S., et al.The amylase inhibitor montbretin A reveals a new glycosidase inhibition motifNat. Chem. Biol.11(9)691-696(2015) 3.Irmisch, S., Jo, S., Roach, C.R., et al.Discovery of UDP-glycosyltransferases and BAHD-acyltransferases involved in the biosynthesis of the antidiabetic plant metabolite montbretin APlant Cell30(8)1864-1886(2018) 4.Yuen, V.G., Coleman, J., Withers, S.G., et al.Glucose lowering effect of montbretin A in Zucker diabetic fatty ratsMol. Cell Biochem.411(1-2)373-381(2016)

レビュー

Review for Montbretin A

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Montbretin A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.